BridgeBio Pharma, Inc. (BBIO)

BridgeBio Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 12, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	9,790	5,186	7,023	1,139	2,455	8,716
Market Cap Growth	72.98%	-26.16%	516.57%	-53.61%	-71.83%	101.23%
Enterprise Value	10,891	6,661	8,229	2,271	3,264	8,544
Last Close Price	51.21	27.44	40.37	7.62	16.68	71.11
PS Ratio	41.19	23.37	754.92	14.67	35.22	1056.59
PB Ratio	-	-3.56	-5.23	-0.91	-2.84	80.79
P/TBV Ratio	-	-	-	-	-	150.52
EV/Sales Ratio	46.19	30.02	884.51	29.25	46.81	1035.70
Debt / Equity Ratio	-1.04	-1.19	-1.30	-1.38	-1.99	4.60
Asset Turnover	0.25	0.30	0.02	0.10	0.08	0.01
Quick Ratio	4.74	4.44	3.04	4.03	6.34	6.35
Current Ratio	5.19	4.67	3.32	4.52	6.58	6.72
Return on Equity (ROE)	-	-	-	-	-	-173.15%
Return on Assets (ROA)	-41.96%	-47.83%	-64.08%	-35.80%	-41.75%	-44.42%
Return on Capital (ROIC)	-108.17%	-104.60%	-85.54%	-43.72%	-48.94%	-50.63%
Earnings Yield	-7.93%	-10.33%	-9.16%	-42.24%	-22.91%	-5.15%
FCF Yield	-6.71%	-10.06%	-7.53%	-37.25%	-20.82%	-4.67%
Buyback Yield / Dilution	-7.74%	-14.30%	-10.39%	-2.16%	-22.34%	-12.27%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q